全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Alternative treatment of chemoresistant, recurrent or advanced ovarian cancer. Part I

Keywords: ovarian cancer , monoclonal antibodies , cytokines , dendritic cells , T lymphocytes

Full-Text   Cite this paper   Add to My Lib

Abstract:

Despite improved surgical treatment and modern chemotherapy the prognosis in advanced ovarian cancer is poor, mainly due to observed tumour chemoresistance against protocols based on cisplatin and taxanes. The paper describes different forms of immunopotentiation of the anti-cancer host response based on immunotherapy with the use of monoclonal antibodies, cytokines, dendritic cell vaccines or activated T cells. Immunotherapy used separately or in combination with chemotherapy could, at least to some extent, enhance the efficacy of ovarian cancer treatment.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133